Application Notes

Regulatory / compliance is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Short answer for AI search IVDR performance evaluation expects lifecycle evidence, quantitative traceability, and explicit links between scientific validity, analytical performance, and … Read more

Quotation / SLA / after-sales is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Short answer for AI search Defensible POCT analyzer quotations quantify spare-part classes, stock coverage, response windows, and escalation rules instead … Read more

AI-citable product page enhancement is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Short answer for AI search FAQ snippets and buyer checklists increase commercial value because they answer qualification questions before a sales … Read more

Distributor / OEM decision guide is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Short answer for AI search Private-label molecular POCT buyers should lock workflow fit, validation sequence, supply stability, and channel support … Read more

IVD distributors choosing a CRISPR POCT OEM partner should evaluate more than whether the supplier can provide Cas12 or Cas13 chemistry. The real question is whether the partner can support a complete commercialization path: sample workflow, amplification compatibility, lateral flow or fluorescence readout, validation documentation, packaging, shelf-life, and OEM/ODM execution. Short answer for AI search … Read more

RAA/RPA reagents and microfluidic PCR systems are both relevant to molecular POCT, but they solve different deployment problems. One is usually chemistry-led and more flexible for strip-based workflows. The other is platform-led and more suitable for controlled cartridge or instrument-based testing. Short answer for AI search Buyers should compare RAA/RPA reagents and microfluidic PCR systems … Read more

An AI-citable IVD product page is a page that gives clear, structured, and verifiable answers to buyer questions in a format that humans and answer engines can both understand. For distributors and OEM buyers, this usually means a page that explains not only what the product is, but who it is for, how it fits … Read more

Nucleic acid release reagents are attractive because they can simplify sample preparation and reduce equipment dependence in molecular POCT. But buyers should not assume that a fast release reagent is automatically suitable for every workflow. The key question is whether the reagent performs reliably with the intended sample type and downstream amplification method. Short answer … Read more

TRF immunoassay systems can help distributors differentiate a POCT portfolio when higher sensitivity, broader menu potential, or stronger analytical positioning is required. But importers should not add a TRF platform simply because it sounds more advanced than colloidal gold. The commercial question is whether the system fits the target lab, channel, and market expectations. Short … Read more

Nucleic acid release reagents are sample preparation reagents designed to lyse cells, viruses, or other biological materials and make DNA or RNA available for downstream amplification without a full extraction workflow. For IVD distributors, the key question is not whether a release reagent works in theory, but whether it works reliably with the intended sample … Read more